Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients

European Journal of Clinical Pharmacology

Volumn 50, Issue 3, 1996, Pages 155-159

  Kantola, I ^a   Terent A ^b   Honkanen, T ^c   Jarvelainen V ^d   Ekman, K ^e   Kataja, M ^f  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c Hämeentie Medical Center   (Finland)

^d Kuntoutusyhtymä Rehab Group Oy   (Finland)

^e Sandoz Oy   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

ACE inhibitor, elderly; Hypertension, Spirapril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRAPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HEADACHE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0029906405     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050085     Document Type: Article

References (15)

1. Fairhurst GJ (1994) A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. Blood pressure 3 [Suppl 2]:77-80
2. Guitard C, Alvisi V, Maibach E, Franck J, Cocco G, Boxho G, Mellein B, Waite R (1994) Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension. Blood Pressure 3 [Suppl 2]:81-87
3. Hayduk K, Schardt F, Sierakowski B, Weidinger G, Welzel D (1994) Single daily administration of spirapril in the treatment of essential hypertension. Blood Pressure 3 [Suppl 2]:41-46
4. Vreugdenhil G, vanMontfrans GA, Jacobs MC, De Bruijn JHB, Veerman DP, vanEs PN, Mellein B, Guitard C, Thien T, DeLeevw PW (1994) 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison. Blood Pressure 3 [Suppl 2]:23-30
5. SHEP Co-operation Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 265:3255-3264
6. Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P-O (1991) Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 338:1281-1285
7. Medical Research Council Working Party (1992) MRC trial of treatment of hypertension in older adults: principal results. Br Med J 304:405-412
8. Beard K, Bulpitt C, Mascie-Taylor H, O'Malley K, Sever P, Webb S (1992) Management of elderly patients with sustained hypertension. Br Med J 304:412-416
9. Jenkins AC, Knill JR, Dreslinski GR (1985) Captopril in the treatment of the elderly hypertensive patient. Arch Intern Med 145:2029-2031
10. Ajayi AA, Hockings N, Reid JL (1986) Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. Br J Clin Pharmacol 21:349-357
11. Laher MS, Natin D, Rao SK, Jones RW, Carr P (1987) Lisinopril in elderly patients with hypertension. J Cardiovasc Pharmacol 9 [Suppl 3]: S69-S71
12. Cox JP, Duggan J, O'Boyle CA, Mee F, Walsh JB, Coakley D, O'Brien E, O'Malley K (1989) A double-blind evaluation of captopril in elderly hypertensives. J Hypertens 7:299-303
13. The fifth report of the Joint National Committee. On detection, evaluation, and treatment of high blood pressure. NIH Publication No. 93-1008, p 1
14. Holzgreve H, Middeke M (1993) Treatment of hypertension in the elderly. Drugs 46 [Suppl 2]:24-31
15. Israili ZH, Hall WD (1992) Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Interm Med 117:234-242